Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (451-460 of 594) with videos related to

Pageof 60
Sort By:
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Circulation Research|April 26, 2017
Human Alternative Macrophages Populate Calcified Areas of Atherosclerotic Lesions and Display Impaired RANKL-Induced Osteoclastic Bone Resorption ActivityGiulia Chinetti-Gbaguidi, Mehdi Daoudi, Mickael Rosa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2004
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulationHélène Duez, Bruno Lefebvre, Philippe Poulain, et al.
Free Radical Biology & Medicine|December 19, 2016
DHA-derived oxylipins, neuroprostanes and protectins, differentially and dose-dependently modulate the inflammatory response in human macrophages: Putative mechanisms through PPAR activationRémy Bosviel, Laurie Joumard-Cubizolles, Giulia Chinetti-Gbaguidi, et al.
Nature Communications|February 9, 2026
Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidityVincent Pascat, Liudmila Zudina, Lucas Maurin, et al.
European Journal of Medicinal Chemistry|March 21, 2026
Discovery of pyrimidine-based small activators of insulin degrading enzymeJamal El Bakali, Cyril Ronco, Valérie Landry, et al.
Molecular and Cellular Biology|December 14, 2011
Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sitesMichael Boergesen, Thomas Åskov Pedersen, Barbara Gross, et al.
Journal of the American Society of Nephrology : JASN|May 24, 2014
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotypeRukshana Shroff, Thimoteus Speer, Sophie Colin, et al.
Circulation|March 27, 2002
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery diseaseDavid M Flavell, Yalda Jamshidi, Emma Hawe, et al.
Plos One|March 10, 2012
Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentKristiaan Wouters, Céline Cudejko, Marion J J Gijbels, et al.
Pageof 60

Showing results (451-460 of 594) with videos related to

Sort By:
Pageof 60
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Circulation Research|April 26, 2017
Human Alternative Macrophages Populate Calcified Areas of Atherosclerotic Lesions and Display Impaired RANKL-Induced Osteoclastic Bone Resorption ActivityGiulia Chinetti-Gbaguidi, Mehdi Daoudi, Mickael Rosa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2004
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulationHélène Duez, Bruno Lefebvre, Philippe Poulain, et al.
Free Radical Biology & Medicine|December 19, 2016
DHA-derived oxylipins, neuroprostanes and protectins, differentially and dose-dependently modulate the inflammatory response in human macrophages: Putative mechanisms through PPAR activationRémy Bosviel, Laurie Joumard-Cubizolles, Giulia Chinetti-Gbaguidi, et al.
Nature Communications|February 9, 2026
Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidityVincent Pascat, Liudmila Zudina, Lucas Maurin, et al.
European Journal of Medicinal Chemistry|March 21, 2026
Discovery of pyrimidine-based small activators of insulin degrading enzymeJamal El Bakali, Cyril Ronco, Valérie Landry, et al.
Molecular and Cellular Biology|December 14, 2011
Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sitesMichael Boergesen, Thomas Åskov Pedersen, Barbara Gross, et al.
Journal of the American Society of Nephrology : JASN|May 24, 2014
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotypeRukshana Shroff, Thimoteus Speer, Sophie Colin, et al.
Circulation|March 27, 2002
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery diseaseDavid M Flavell, Yalda Jamshidi, Emma Hawe, et al.
Plos One|March 10, 2012
Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentKristiaan Wouters, Céline Cudejko, Marion J J Gijbels, et al.
Pageof 60